BrainsWay announces collaboration with Inland Psychiatric Medical Group in Southern California

BrainsWay Ltd. announced on October 19, 2026 a strategic collaboration with Inland Psychiatric Medical Group, described as an established provider of comprehensive behavioral health services across Southern California.¹

IPMG runs a multidisciplinary practice that serves patients throughout Southern California, including in Riverside, San Bernardino, Los Angeles, and Orange Counties.¹ The group's offerings span psychiatry, medication management, psychotherapy, TMS therapy, esketamine treatment, and clinical research.¹

Under the arrangement, BrainsWay said the collaboration includes a multisystem order of BrainsWay Deep TMS systems planned for installation at IPMG clinics, along with exploration of scientific, clinical and research projects aimed at expanding interventional psychiatry and mental health care.¹

BrainsWay CEO Hadar Levy said the company is proud to establish the partnership with IPMG in pursuit of a shared goal of improving patients' lives through interventional psychiatry treatments, calling it part of a strategy of building relationships with key accelerators of innovation in mental health.¹

The release describes the Deep TMS device as a therapy delivered via a patented coil design housed within a cushioned, patient and provider-friendly helmet,¹ which works by pulsing a magnetic field that targets affected brain structures to stimulate underactive neural networks.¹ According to the company, the device holds FDA clearance to treat major depressive disorder, including reduction of anxiety symptoms commonly referred to as anxious depression, obsessive-compulsive disorder, and smoking addiction.¹

BrainsWay also said it is the first and only TMS company to obtain three FDA-cleared indications supported by pivotal clinical studies, according to the company.¹ The filing notes additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway.¹ BrainsWay was founded in 2003 and operates in the United States and Israel.¹